EUTM file information

018279395

CARTANA

July 28, 2020

Trademark Summary

The trademark application CARTANA was filed by CartaNA AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on August 30, 2020, and it was registered by office on December 7, 2020 without any oppositions.

It was designated 'Basic Application' for International Application 1556412 at the World Intellectual Property Organization (WIPO).

The application was filed in Swedish (English was selected as the second language).

Partial Surrender of the trademark registration was recorded on February 21, 2021. Change of name and professional address of the trademark registration was recorded on July 14, 2022.

Goods And Services

  • The mark was filed in class 1 with following description of goods:
    1. Chemicals used in scientific analysis, research and diagnostic use
    2. Chemicals for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics
    3. Chemicals kits including oligonucleotides, reagent buffers, enzymes, detection solutions, fluorophores for research and diagnostics use and drug development purpose
    4. Reagents for microfluidic instruments for non-medical use.
  • The mark was filed in class 5 with following description of goods:
    1. Diagnostic reagents for medical use in the field of cancer
    2. Diagnostic reagents for clinical or medical laboratory use, namely, for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics
    3. Diagnostic reagents for detection of gene mutation for clinical, oncology, and hematology diagnostics
    4. Diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer
    5. Chemical reagents for medical use
    6. Diagnostic test kits for medical use comprising primarily of reagents, slides, solid matrix materials, microfluidic devices sold as a unit
    7. Medical diagnostic test kits for detecting pathogens, comprising primarily reagents, slides, solid matrix materials, microfluidic devices sold as a unit
    8. Medical diagnostic reagents for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of polymorphisms, analysis of functional pathway gene sets, diagnostics, companion diagnostics
    9. Reagents for microfluidic instruments for medical use
    10. Kits for research use, diagnostics use and drug development namely oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores
    11. Kits for research use, diagnostics use and drug development namely oligonucleotides, reagent buffers, enzymes, detection solutions and fluorophores.
  • The mark was filed in class 9 with following description of goods:
    1. Apparatus and instruments for scientific and diagnostic use
    2. Apparatus and instruments used for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets, diagnostics, companion diagnostics
    3. Appartus and instruments for detection of gene mutation for clinical, oncology, and hematology diagnostics
    4. Apparatus, instruments and software used in scientific analysis, RNA expression profiling, detection of RNA, image analysis and cell segmentation for research and diagnostic use
    5. Microfluidic instruments for non-medical use
    6. Apparatus, instruments and software used in scientific analysis, RNA expression profiling and detection of RNA for research and diagnostic use.
  • The mark was filed in class 10 with Apparatus and instruments used for in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets, diagnostics, companion diagnostics for medical use and microfluidic instruments for medical use..
  • The mark was filed in class 42 with following description of goods:
    1. Research, development and diagnostics services for others regarding in situ RNA sequencing, RNA transcription profiling, detection of RNA in tissue samples, microRNA expression profiling, detection of single nucleotide polymorphisms, analysis of functional pathways gene sets
    2. Drug development
    3. Diagnostic and companion diagnostic development
    4. Data science (biostatistics) services
    5. Laboratory biomarker analysis services and related data analysis
    6. Image analysis and cell segmentation services
    7. Medical and scientific research.
  • The mark was filed in class 44 with following description of goods:
    1. Medical services
    2. Medical diagnostic services
    3. Veterinary services
    4. Veterinary diagnostic services.
Trademarkers